The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

KIR2DL5A  -  killer cell immunoglobulin-like receptor,...

Homo sapiens

Synonyms: CD158F, CD158F1, KIR2DL5, KIR2DL5.1, KIR2DL5.3, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on KIR2DL5A

  • Ab-mediated cross-linking of KIR2DL5 inhibits NK cell cytotoxicity against murine FcR(+) P815 cells [1].
  • Like other MHC class I receptors, KIR2DL5 is also found in a variable proportion of T lymphocytes [1].
  • KIR2DL5 is detected on the cell surface as a monomer of approximately 60 kDa that, upon tyrosine phosphorylation, recruits the Src homology region 2-containing protein tyrosine phosphatase-2 and, to a lesser extent, Src homology region 2-containing protein tyrosine phosphatase-1 [1].
  • KIR2DL5 is thus an inhibitory receptor gathering a combination of genetic, structural, and functional features unique among KIR, which suggests that KIR2DL5 plays a specialized role in innate immunity [1].
  • KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) [2].
 

Biological context of KIR2DL5A

 

Anatomical context of KIR2DL5A

  • One gene, KIR2DL5, is expressed by subpopulations of NK cells and T cells, whereas expression of the other three genes could not be detected [5].
  • KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains [5].
 

Other interactions of KIR2DL5A

  • KIR2DL5 has two extracellular Ig-like domains of the D0 and D2 type, a structural configuration that was previously unique to KIR2DL4 [5].

References

  1. Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets. Estefanía, E., Flores, R., Gómez-Lozano, N., Aguilar, H., López-Botet, M., Vilches, C. J. Immunol. (2007) [Pubmed]
  2. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). Yusa, S., Catina, T.L., Campbell, K.S. J. Immunol. (2004) [Pubmed]
  3. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Gómez-Lozano, N., Gardiner, C.M., Parham, P., Vilches, C. Immunogenetics (2002) [Pubmed]
  4. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. Vilches, C., Gardiner, C.M., Parham, P. J. Immunol. (2000) [Pubmed]
  5. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. Vilches, C., Rajalingam, R., Uhrberg, M., Gardiner, C.M., Young, N.T., Parham, P. J. Immunol. (2000) [Pubmed]
  6. Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France. Frassati, C., Touinssi, M., Picard, C., Segura, M., Galicher, V., Papa, K., Gagne, K., Vivier, E., Degioanni, A., Böetsch, G., Mercier, P., Vély, F., de Micco, P., Reviron, D., Chiaroni, J. Tissue Antigens (2006) [Pubmed]
 
WikiGenes - Universities